Results

Total Results: 1,277 records

Showing results for "death".

221. Omega 3 Fatty Acids and Cardiovascular Disease - Update | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/fatty-acids-cardiovascular-disease/research-protocol
     December 01, 2020 - death. … Effects of omega-3 fatty acid for sudden cardiac death prevention in patients with cardiovascular disease … Do omega-3 polyunsaturated fatty acids reduce risk of sudden cardiac death and ventricular arrhythmias … Prevention of sudden cardiac death with omega-3 fatty acids in patients with coronary heart disease: … exp death, sudden/ 75. (sudden adj death).mp.

222. Patient-Monitoring-Systems-Appendix-C (xls file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/patient-monitoring-systems-appendix-c.xlsx
     January 01, 2024 - Composite outcome (unexpected cardiac arrests, unplanned ICU admissions and death) One randomised study … ) NR Reference Continuity adjusted confidence limits Bassin, 2023 Arm 2 Post-intervention (DI+EWS) Death … and admitting unit and service Gallo, 2024 Arm 1 -Usual care/In person Maximum EDI <65 In-patient death … Rates of the secondary outcome (RRT activation, ICU transfer, cardiopulmonary arrest, or inpatient death … Rates of the secondary outcome (RRT activation, ICU transfer, cardiopulmonary arrest, or inpatient death

223. Disposition of Comments: Comparative Effectiveness Review No. 273_Treatment of Stages I-III Squamous Cell Anal Cancer: A Systematic Review (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-273-anal-cancer-disposition-comments.pdf
     August 20, 2024 - Riechelmann Discussion and Conclusions "Therefore, the null findings for OS might be explained by death

224. Maternal and Fetal Effects of Mental Health Treatments in Pregnant and Breastfeeding Women: A Systematic Review of Pharmacological Interventions (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/protocol-pharm-pregnant-women_0.pdf
     December 05, 2018 - Miscarriage, danger to self or infant, misuse of prescription medication, treatment- related harms, death … Fetus/Infant/Child: Death, preterm birth/small or large for gestational age, congenital anomalies, … self or infant o Misuse of prescription medication o Serious adverse events related to treatment o Death … o Poor infant attachment/bonding*† o Delayed social, emotional, and cognitive development* o Death … Homicide and suicide during the perinatal period: findings from the National Violent Death Reporting

225. Postpartum Home Blood Pressure Monitoring, Postpartum Treatment of Hypertensive Disorders of Pregnancy, and Peripartum Magnesium Sulfate Regimens for Preeclampsia With Severe Features | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/hypertensive-disorders-pregnancy/protocol
     April 01, 2022 - In addition to the increased risks of death and serious complications, postpartum HDP can have important

226. Appendix A: Literature Search (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/postpartum-care-protocol-appendix%20A.pdf
     December 09, 2021 - portable OR "Health education" OR Contracept* OR insurance expansion OR Medicaid expansion OR "Maternal Death … * OR telemedicine OR telehealth) OR "insurance expansion" OR "Medicaid expansion" OR (MH "Maternal Death

227. A Systematic Review of Postpartum Home Blood Pressure Monitoring, Postpartum Treatment of Hypertensive Disorders of Pregnancy, and Peripartum Magnesium Sulfate Regimens for Preeclampsia With Severe Features (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/product/pdf/hypertensive-disorders-pregnancy-protocol-amendment.pdf
     April 20, 2022 - In addition to the increased risks of death and serious complications, postpartum HDP can have important

228. #14 SUBSTANCE ABUSE (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1506.pdf
     June 01, 2015 - #14 SUBSTANCE ABUSE AHRQ Healthcare Horizon Scanning System – Potential High-Impact Interventions Report Priority Area 14: Substance Abuse Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 540 Gaither Road Rockville, MD 20850 www.ahrq.…

229. The Role of Immunotherapy and the Management of Asthma: Systematic Review | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/asthma-immunotherapy/research-protocol
     April 01, 2021 - between patients and over time in the same patient, asthma can be fatal, accounting for approximately 1 death … Control Test (ACT) Asthma Control Questionnaire (ACQ) Pediatric Asthma Control Test (PACQ) Death … Hypersensitivity reaction Other adverse effects of immunotherapy (local and systemic effects) Death … For key questions 2 and 4 we will grade harms: anaphylaxis, hypersensitivity adverse effects and death … include rapidly progressing URTICARIA, respiratory distress, vascular collapse, systemic SHOCK, and death

230. Radiation Therapy for Brain Metastases | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/radiation-therapy-brain-metastases/research
     January 01, 2022 - ratio [HR], 1.09; confidence interval [CI], 0.69 to 1.73; 4 RCTs; low strength of evidence [SoE]) or death

231. Pulmonary Arterial Hypertension: Screening, Management, and Treatment | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/hypertension-pulmonary-arterial/research
     December 01, 2019 - progresses to right ventricular pressure overload, dysfunction, right heart failure, and premature death

232. Adverse Events Associated with COVID-19 Pharmaceutical Treatments | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/COVID-19-pharmaceutical-treatments/research
     September 01, 2023 - development, distribution, and use of countermeasures by providing compensation for serious injuries or death … statement of certainty on the association of each countermeasure with each serious adverse event or death

233. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/cad-women-diagnosis_research-protocol.pdf
     June 06, 2011 - Clinical outcomes (e.g., death, myocardial infarction, unstable angina, hospitalization, revascularization … percutaneous coronary intervention, coronary artery bypass surgery) - Clinical outcomes (e.g., death … offered, and clinical outcomes (including myocardial infarction, unstable angina, hospitalization, death …  Prevalence Clinical outcomes  Myocardial infarction  Unstable angina  Hospitalization  Death … bypass graft Clinical outcomes: o Myocardial infarction o Unstable angina o Hospitalization o Death

234. Layout 1 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/atypical-antipsychotics-off-label_executive.pdf
     January 01, 2007 - In a recently published meta-analysis of 15 dementia treatment trials, death occurred in 3.5 percent … The odds ratio for death was 1.54, with a 95-percent CI of 1.06 to 2.23. … The difference in risk for death was small but statistically significant. … Effectiveness) Network suggest that conventional antipsychotics are also associated with an increased risk of death … While the increased risk of death in elderly dementia patients treated with atypical antipsychotics was

235. 1. Does mass spectrometric analysis and therapeutic monitoring of tacrolimus as compared with immunoassay analysis and therapeutic monitoring produce a) better organ survival rate, b) fewer rejections, c) less nephrotoxicity and/or d) cost… | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/1-does-mass-spectrometric-analysis-and-therapeutic-monitoring-of-tacrolimus-as-compared-with-immunoassay-analysis-and-therapeutic-monitoring-produce-a-better-organ-survival-rate-b-fewer-rejections-c-less-nephrotoxicity-andor
     November 01, 2017 - Skip to main content An official website of the Department of Health & Human Services Careers Contact Us Español FAQs Effective Health Care Program Powered by the Evidence-based Practice Centers …

236. Fatty-Acids-Cardiovascular-Disease Research-Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/fatty-acids-cardiovascular-disease_research-protocol.pdf
     April 02, 2015 - death. … Effects of omega-3 fatty acid for sudden cardiac death prevention in patients with cardiovascular disease … Do omega-3 polyunsaturated fatty acids reduce risk of sudden cardiac death and ventricular arrhythmias … Prevention of sudden cardiac death with omega-3 fatty acids in patients with coronary heart disease: … (sudden adj death).mp.

237. Layout 1 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-2007_executive.pdf
     January 01, 2007 - following life-threatening adverse events: life- threatening hypoglycemia leading to emergency care or death … Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. … percent confidence interval (CI), 1.03 to 1.98) and a nonsignificant association with cardiovascular death … hazard ratio of 1.08 (95-percent CI, 0.89 to 1.31) for the primary end point of hospitalization or death … In Kaplan-Meier curves, the risk of hospitalization or death from myocardial infarction was slightly

238. Managed Care | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/health-topics/managed-care?page=4
     December 02, 2009 - August 29, 2007 Comparative Safety of Conventional and Atypical Antipsychotic Medications: Risk of Death

239. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/patient-safety-practices_research-protocol.pdf
     November 09, 2011 - health literacy)  Interventions for central venous catheter-related blood infections  Patient death … or serious injury associated with prolonged fluoroscopy with cumulative dose  Death among surgical

240. Methods Guide for Medical Test Reviews - Editorial (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/methods-guide-editorial_methods.pdf
     July 01, 2012 - test to predict clinically significant outcomes (such as 10-year risk of stroke or cardiovascular death … ) or the effect of subsequent carotid endarterectomy or stenting on stroke or death rates.